Alpha-Mannosidosis Disease Severity Assessment

Assesses alpha-mannosidosis severity using intellectual disability degree, hearing impairment, immune deficiency (recurrent infections), ataxia, and psychiatric features to guide laronidase and HSCT decisions.

Weight
Height
Clinical Guidance

BMI is a screening measure of body size, not a direct measure of body fat. The standard WHO categories are underweight (<18.5), normal (18.5–24.9), overweight (25–29.9), and obese (≥30).

BMI can overestimate body fat in athletes with high muscle mass and underestimate it in older adults with low muscle mass. Interpret it alongside waist circumference and clinical context rather than as a standalone diagnosis.

⚕ Clinical Disclaimer: These calculators are for educational and reference purposes only. Always verify results with qualified clinical judgment and current clinical guidelines. Do not use as a sole basis for medical decisions.
Advertisement

How It Works

Assesses alpha-mannosidosis severity using intellectual disability degree, hearing impairment, immune deficiency (recurrent infections), ataxia, and psychiatric features to guide laronidase and HSCT decisions

Each component has a specific meaning:

  • Intellectual disability degree — The intellectual disability degree recorded for the scenario being assessed.
  • Hearing impairment — The hearing impairment recorded for the scenario being assessed.
  • Immune deficiency — The immune deficiency recorded for the scenario being assessed.
  • Ataxia — The ataxia recorded for the scenario being assessed.
  • Psychiatric features — The psychiatric features recorded for the scenario being assessed.

Note: Interpret the mannosidosis severity result against the thresholds and context described above.

How to Use

Enter the intellectual disability degree, hearing impairment, immune deficiency, ataxia, psychiatric features for the scenario you are assessing. Assesses alpha-mannosidosis severity using intellectual disability degree, hearing impairment, immune deficiency (recurrent infections), ataxia, and psychiatric features to guide laronidase and HSCT decisions. Use the mannosidosis severity result to inform your calculation.

Frequently Asked Questions